The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Verdecchia, Paolo, Cavallini, Claudio, Spanevello, Antonio, Angeli, Fabio·2020·European Journal of Internal Medicine
DOI 10.1016/j.ejim.2020.04.037

Cited by (1,000)

Items 201–300 of 1,000

  1. The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
    Hau C. Kwaan, Paul F. Lindholm · 2021 · International Journal of Molecular Sciences
  2. The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection
    Susan Wray, Sarah Arrowsmith · 2021 · Frontiers in Physiology
  3. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
    Nitin Kumar, Yu Zuo, Srilakshmi Yalavarthi, Kristina L. Hunker, Jason S. Knight, Yogendra M. Kanthi, T. Andrea, Santhi K. Ganesh · 2020 · Viruses
  4. Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
    R. Clayton Edenfield, Charles A. Easley · 2021 · Nature Reviews Urology
  5. COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"
    Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, Martina Zappa, Antonio Spanevello, Paolo Verdecchia · 2022 · European Journal of Internal Medicine
  6. Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
    Ana Paula Bouças, Jakeline Rheinheimer, Jim Lagopoulos · 2020 · The Neuroscientist
  7. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
    Sally Badawi, Bassam R. Ali · 2021 · Human Genomics
  8. SARS-CoV-2 (COVID-19) and the Endocrine System
    Michelle Diane Lundholm, Caroline A Poku, Nicholas Emanuele, Mary Ann Emanuele, Norma Lopez · 2020 · Journal of the Endocrine Society
  9. ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role
    C. Calabrese, A. Annunziata, A. Coppola, P. Pafundi, Salvatore Guarino, V. Di Spirito, V. Maddaloni, N. Pepe, G. Fiorentino · 2021 · Frontiers in Medicine
  10. Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19
    Stephanie S. Kulaga, Christopher W. T. Miller · 2021 · Neuroscience & Biobehavioral Reviews
  11. Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis
    Isabella Zaidan, Luciana P. Tavares, Michelle A. Sugimoto, Kátia Maciel Lima, Graziele L. Negreiros-Lima, Lívia Cristina Ribeiro Teixeira, Thaís C. Miranda, Bruno Vinícius Santos Valiate, Allysson Thiago Cramer, Juliana P. Vago et al. · 2021 · JCI Insight
  12. GlycoGrip: Cell Surface-Inspired Universal Sensor for Betacoronaviruses
    Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, Lorenzo Casalino, Micah Papanikolas, Carlos L. Simmerling, Rommie E. Amaro, Ronit Freeman · 2021 · ACS Central Science
  13. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
  14. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm
    Mattia Vinciguerra, Silvia Romiti, Khalil Fattouch, Antonio De Bellis, Ernesto Greco · 2020 · Journal of Clinical Medicine
  15. Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia
    Sara Behbahani, Julia O. Baltz, Rebecca J. Droms, APRIL C. DENG, Shinya U. Amano, Nikki Levin, Mary Callery O'Brien, Karen Wiss · 2020 · JAAD Case Reports
  16. Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
    Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Dina Visca, Fabio Angeli · 2021 · European Journal of Internal Medicine
  17. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
    Jiajing Zheng, Jiameng Miao, Rui Guo, Jinhe Guo, Zheng Fan, Xianbin Kong, Rui Gao, Long Yang · 2022 · Frontiers in Cellular and Infection Microbiology
  18. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
    Helms, Louisa, Marchiano, Silvia, Stanaway, Ian B., Hsiang, Tien-Ying, Juliar, Benjamin A., Saini, Shally, Zhao, Yan Ting, Khanna, Akshita, Menon, Rajasree, Alakwaa, Fadhl et al. · 2021 · JCI Insight
  19. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
    Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Valentina Petito, Daniela Pugliese, Matteo Neri, Giovanni Cammarota, Yehuda Ringel et al. · 2020 · Inflammatory Bowel Diseases
  20. Pathophysiology of Cardiovascular Complications in COVID-19
    Vladimír Petrovič, Dina Radenković, Goran Radenković, Vukica Djordjevic, Maciej Banach · 2020 · Frontiers in Physiology
  21. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
    Toshiaki Iba, Jerrold H. Levy · 2021 · Trends in Cardiovascular Medicine
  22. Long COVID, neuropsychiatric disorders, psychotropics, present and future
    Siu Wa Tang, Brian E. Leonard, Daiga Maret Helmeste · 2022 · Acta Neuropsychiatrica
  23. A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
    Elias Makhoul, Joseph L. Aklinski, Jesse Miller, Cara Leonard, Sean Backer, Payal Kahar, Mayur S. Parmar, Deepesh Khanna · 2022 · Cureus
  24. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
    Desmond Omane Acheampong, Isaac Kyei-Barffour, Alex Boye, Enoch Aninagyei, Stephen Ocansey, Martin Tangnaa Morna · 2020 · Biomedicine & Pharmacotherapy
  25. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Girish Pathangey, Priyal Fadadu, Alexa R. Hospodar, Amr E. Abbas · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  26. A New Sterilization Strategy Using TiO2 Nanotubes for Production of Free Radicals that Eliminate Viruses and Application of a Treatment Strategy to Combat Infections Caused by Emerging SARS-CoV-2 during the COVID-19 Pandemic
    Reham Z. Hamza, Adil A. Gobouri, Hatim M. Al-Yasi, Tarek Al-Talhi, Samy M. El‐Megharbel · 2021 · Coatings
  27. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
    Jeffrey D. Pyne, Adam M. Brickman · 2021 · Neurodegenerative Diseases
  28. Quantifying Renin-Angiotensin-System Alterations in COVID-19
    Fabrizio Pucci, Filippo Annoni, Robson A.S. Santos, Fabio Silvio Taccone, Marianne J. Rooman · 2021 · Cells
  29. Elevated plasma sTIM-3 levels in patients with severe COVID-19
    Thor Ueland, Lars Heggelund, Andreas Lind, Aleksander Rygh Holten, Kristian Tonby, Annika Elisabet Michelsen, Synne Jenum, Marthe Jøntvedt Jørgensen, Andreas Barratt‐Due, Linda Gail Skeie et al. · 2020 · Journal of Allergy and Clinical Immunology
  30. Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
    Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
  31. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
    Hatem A. Elshabrawy · 2020 · Vaccines
  32. Role of brain renin–angiotensin system in depression: A new perspective
    Naif H. Ali, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Rabab S. Hamad, Athanasios T. Alexiou, Marios Papadakis, Hebatallah M. Saad, Gaber El‐Saber Batiha · 2023 · CNS Neuroscience & Therapeutics
  33. A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
    Luise Hassler, Jan A Wysocki, Ian Arthur Gelarden, Isha Sharma, Αναστασία Τοματσίδου, Minghao Ye, Haley Gula, Vlad Nicoleascu, Glenn C. Randall, Sergii Pshenychnyi et al. · 2022 · Journal of the American Society of Nephrology
  34. The potential role of the carotid body in COVID-19
    Andrea Porzionato, Aron Emmi, Elena Stocco, Silvia Barbon, Rafael Boscolo-berto A, Veronica Macchi, Raffaele De · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  35. COVID-19 in Children with Asthma
    Grigorios Chatziparasidis, Ahmad Kantar · 2021 · Lung
  36. Coronavirus disease 2019 and the gut–lung axis
    Dan Dan Zhou, Qiu Wang, Hanmin Liu · 2021 · International Journal of Infectious Diseases
  37. Potential Genes Associated with COVID-19 and Comorbidity
    Shanshan Feng, Fu-Qiang Song, Wenqiong Guo, Jishan Tan, Xianqin Zhang, Fengling Qiao, Jinlin Guo, Lin Zhang, Xu Jia · 2022 · International Journal of Medical Sciences
  38. The Immunopathology of COVID-19 and the Cannabis Paradigm
    Nicole Paland, Antonina Pechkovsky, Miran Aswad, Haya Hamza, Tania Popov, Eduardo Shahar, Igal Louria‐Hayon · 2021 · Frontiers in Immunology
  39. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates
    Eric R. Sang, Yun Tian, Laura C. Miller, Yongming Sang · 2021 · Genes
  40. Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
    Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, Gabriella Santilli, Martina Zappa, Paolo Verdecchia · 2022 · Journal of Cardiovascular Development and Disease
  41. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
    Zahra Khoshkam, Younes Aftabı, Peter Stenvinkel, B. Paige Lawrence, Mehran Habibi-Rezaei, Gaku Ichihara, Sasan Fereidouni · 2021 · Journal of Advanced Research
  42. Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
    Sara Taha, Sara Farid Samaan, Rehab Ali Ibrahim, Eman Mousa El-Sehsah, Mariam Karam Youssef · 2021 · European Cytokine Network
  43. Role of Endothelium in Cardiovascular Sequelae of Long COVID
    Luca Santoro, Vincenzo Zaccone, Lorenzo Falsetti, Vittorio Ruggieri, Martina Danese, Chiara Miro, Angela Di Giorgio, Antonio Nesci, Alessia D’Alessandro, Gianluca Moroncini et al. · 2023 · Biomedicines
  44. How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
    Małgorzata Kloc, Rafik Mark Ghobrial, Jacek Z. Kubiak · 2020 · Immunology Letters
  45. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists
    U. Muscha Steckelings, Colin Sumners · 2020 · Clinical Science
  46. ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
    Véronique Michaud, Malavika Deodhar, Meghan J. Arwood, Sweilem B. Al Rihani, Pamela Dow, Jacques Turgeon · 2020 · Journal of Clinical Medicine
  47. Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?
    Mallikarjun Patil, Sarojini Singh, John Henderson, Prasanna Krishnamurthy · 2020 · Journal of Cellular Physiology
  48. An overview of human proteins and genes involved in SARS-CoV-2 infection
    Zohreh Jahanafrooz, Zhishan Chen, Jiandong Bao, Hongzhi Li, Loren P. Lipworth, Xingyi Guo · 2021 · Gene
  49. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
    María Laura Sáiz, Marta L. DeDiego, Darío López-García, Viviana Corte-Iglesias, Aroa Baragaño Raneros, Iván Astola, Víctor Asensi, Carlos López‐Larrea, Beatriz Suárez-Álvarez · 2021 · Clinical Epigenetics
  50. Epigenetic mechanisms regulate sex-specific bias in disease manifestations
    Sarantis Chlamydas, Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · Journal of Molecular Medicine
  51. Angiotensin II receptors: Impact for COVID ‐19 severity
    Hasan K. Aksoy, Ayşe Serap Karadağ, Uwe Wollina · 2020 · Dermatologic Therapy
  52. The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer’s Disease and Aging: A Review of Knowledge
    Claire-Marie Rangon, Slavica M Krantic, Emmanuel Moyse, Bertrand Fougère · 2020 · Journal of Alzheimer s Disease Reports
  53. COVID-19: A Redox Disease—What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment
    Andrew F. Cumpstey, Anna D. Clark, Jérôme Santolini, Alan A. Jackson, Martin Feelisch · 2021 · Antioxidants and Redox Signaling
  54. Platelet extracellular vesicles in COVID-19: Potential markers and makers
    Florian Puhm, Louis Flamand, Éric Boilard · 2021 · Journal of Leukocyte Biology
  55. Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers
    Alphus Dan Wilson, Lisa Beth Forse · 2023 · Sensors
  56. ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection
    Shimaa Abdelsattar, Zeinab Abdel Aziz Kasemy, Suzy Fayez Ewida, Reda A. A. Abo-Elsoud, A. A. Zytoon, Gehan Ali Abdelaal, Ahmed S. Abdelgawad, Fatma Omar Khalil, Hala F. M. Kamel · 2022 · British Journal of Biomedical Science
  57. Intestinal barrier dysfunction as a key driver of severe COVID-19
    Efthymios P. Tsounis, Christos K Triantos, Christos Konstantakis, Markos N. Marangos, Stelios F. Assimakopoulos · 2023 · World Journal of Virology
  58. Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
    Min Li, Sanpeng Li, Yixuan Huang, Haixia Chen, Songya Zhang, Zhicheng Zhang, Weigang Wu, Xiaobin Zeng, Boping Zhou, Bin Li · 2021 · Advanced Materials
  59. Are Older People Really More Susceptible to SARS-CoV-2?
    Zhang, Shuo, Yang, Zhen, Li, Zhuo-Ning, Chen, Zhen-Lin, Yue, Shi-Jun, Fu, Rui-Jia, Xu, Ding-Qiao, Zhang, Sai, Tang, Yu-Ping · 2022 · Aging and disease
  60. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
    Murtala Bello Abubakar, Dawoud Usman, Gaber El‐Saber Batiha, Natália Alves Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Idris Muhammad, Siew Hua Gan et al. · 2021 · Frontiers in Pharmacology
  61. COVID-19 Immunobiology: Lessons Learned, New Questions Arise
    Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas · 2021 · Frontiers in Immunology
  62. Is Covid-19 Severity Associated With ACE2 Degradation?
    Ugo Bastolla, Patrick William Chambers, David Abia, Laura García‐Bermejo, Manuel Fresno · 2022 · Frontiers in Drug Discovery
  63. Men and COVID-19: A Pathophysiologic Review
    Martin Stephen Lipsky, Man Hung · 2020 · American Journal of Men s Health
  64. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer’s and Parkinson’s Diseases in Young Urbanites Exposed to Air Pollution
    Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Maricela Franco-Lira, Randy Joseph Kulesza, Angélica González-Maciel, Rafael Reynoso-Robles, Rafael Brito-Aguilar, Berenice García-Arreola, Paula Revueltas-Ficachi, Juana Adriana Barrera-Velázquez et al. · 2020 · Journal of Alzheimer s Disease
  65. Testis and blood-testis barrier in Covid-19 infestation: role of angiotensin-converting enzyme 2 in male infertility
    Olugbemi Tope Olaniyan, Ayobami Dare, Gloria Enevwo Okotie, Charles Oluwaseun Adetunji, Babatunde Oluwaseun Ibitoye, Bamidele Joseph Okoli, Olugbenga O. Eweoya · 2020 · Journal of Basic and Clinical Physiology and Pharmacology
  66. Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint
    Taruneet Kaur, Suman Kapila, Rajeev Kapila, Sandeep Kumar, Divya Upadhyay, Manjeet Kaur, Chandresh Sharma · 2021 · Virus Research
  67. Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study
    Pradeep Kumar Yadalam, Varatharajan Kalaivani, K. Rajapandian, Priyanka Chopra, Deepavalli Arumuganainar, Thilgavathi Nagarathnam, Honglae Sohn, Thirumurthy Madhavan · 2021 · Frontiers in Chemistry
  68. Hypoxia and viral infectious diseases
    Richard Huang, Melissa Huestis, Esther Shuyi Gan, Eng Eong Ooi, Michael Ohh · 2021 · JCI Insight
  69. Predictors of Mortality in Critically Ill COVID‐19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
    Višeslav Popadić, Slobodan Klašnja, Natasa M Milic, Nina Rajović, Aleksandra Aleksic, Marija Milenkovic, Bogdan Crnokrak, Bela Balint, Milena Todorović, Davor Mrda et al. · 2021 · Oxidative Medicine and Cellular Longevity
  70. COVID-19 and obesity: fighting two pandemics with intermittent fasting
    Kafi N. Ealey, J Cole Phillips, Hoon‐Ki Sung · 2021 · Trends in Endocrinology and Metabolism
  71. The Role of Endothelium in COVID-19
    Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, Dragoş Şerban, Domenico Nuzzo, Laura Mazilu, Andra‐Iulia Suceveanu, Ana Maria Dascălu, Irinel Raluca Parepa · 2021 · International Journal of Molecular Sciences
  72. Probiotics and COVID-19
    Giancarlo Ceccarelli, Carolina Scagnolari, Francesco Rocco Pugliese, Claudio Maria Mastroianni, Gabriella d’Ettorre · 2020 · The Lancet. Gastroenterology & hepatology
  73. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients
    Małgorzata Kloc, Rafik Mark Ghobrial, Agnieszka Lipińska‐Opałka, Agata Wawrzyniak, Robert Zdanowski, Bolesław Kalicki, Jacek Z. Kubiak · 2020 · Cellular Immunology
  74. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
    Sara Chiappalupi, Laura Salvadori, Aleksandra Vukašinović, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi · 2021 · Life Sciences
  75. Human genetic basis of coronavirus disease 2019
    Hao Deng, Xue Yan, Lamei Yuan · 2021 · Signal Transduction and Targeted Therapy
  76. The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
    Wanchen Song, Zhongbiao Fang, Feike Ma, Jiaxuan Li, Zhiwei Huang, Yanjun Zhang, Jianhua Li, Keda Chen · 2023 · Frontiers in Microbiology
  77. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
    Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar‐Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello R Retamal-Díaz, Susan M. Bueno, Pablo A. González et al. · 2024 · Frontiers in Immunology
  78. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?
    Sabrina Rahman Archie, Luca Cucullo · 2020 · International Journal of Molecular Sciences
  79. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
    Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Sara Paone, Miriam Scicchitano, Roberta Macrì, Saverio Nucera, Francesca Bosco et al. · 2020 · International Journal of Molecular Sciences
  80. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Bettina Hohberger, Marion Ganslmayer, Marianna Lucio, Friedrich Eduard Kruse, Jakob Hoffmanns, Michael Moritz, Lennart Rogge, Felix Heltmann, Charlotte Szewczykowski, Julia Fürst et al. · 2021 · Frontiers in Medicine
  81. COVID-19 and Cardiovascular Disease
    Shivani G Varmani, Rimpy Kaur Chowhan, Ishani Sharma, Rajiv Narang · 2021 · Journal of the Practice of Cardiovascular Sciences
  82. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
    Yasutomi Higashikuni, Wenhao Liu, Takumi Obana, Masataka Sata · 2021 · International Journal of Molecular Sciences
  83. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms
    Mark Aaron Cappel, Jonathan A. Cappel, David A. Wetter · 2021 · Mayo Clinic Proceedings
  84. Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study
    Tian‐Yuan Xiong, Fang-Yang Huang, Qi Liu, Yong Peng, Yuan-Ning Xu, Jia-Fu Wei, Nian Li, Bei Bai, Junhua Li, Bernard Prendergast et al. · 2020 · Annals of Medicine
  85. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
    Upinder Kaur, K. Kshitish Acharya, Ritwick Mondal, Amit Kumar Singh, Luciano Saso, Sasanka Chakrabarti, Sankha Shubhra Chakrabarti · 2020 · European Journal of Pharmacology
  86. Targeting Crucial Host Factors of SARS-CoV-2
    Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li · 2020 · ACS Infectious Diseases
  87. Global Research on COVID-19 Disease: A Scientific Assessment of Publications during 2020-21
    BM Gupta, SM Dhawan, KK Mueen Ahmed, Ghouse Modin Nabeesab Mamdapur · 2021 · International Journal of Medicine and Public Health
  88. COVID-19 Outcome Relates With Circulating BDNF, According to Patient Adiposity and Age
    Luciéle Guerra Minuzzi, Marília Cerqueira Leite Seelaender, Bruna Spolador de Alencar Silva, Eduardo del Bosco Brunetti Cunha, Marina de Castro Deus, Franciane F. Vasconcellos, Luis Felipe Marqueze, Ana Carolina Gadotti, Cristina Pellegrino Baena, Telmo Santos Pereira et al. · 2021 · Frontiers in Nutrition
  89. The Impact ofACEandACE2Gene Polymorphisms in Pulmonary Diseases Including COVID-19
    Iphigenia Gintoni, Μαρία Αδαμοπούλου, Christos Yapijakis · 2021 · In Vivo
  90. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
    Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
  91. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
    Harry F. Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis, Irene Ligielli, Graham J. Moore, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Thomas Mavromoustakos, John Matsoukas · 2022 · Viruses
  92. Central Nervous System Manifestations of COVID-19: A Critical Review and Proposed Research Agenda
    Kelsey C. Hewitt, David E. Marra, Cady K. Block, Lucette A. Cysique, Daniel L. Drane, Michelle M. Haddad, Emilia Łojek, Carrie R. McDonald, Anny Reyes, Kara Eversole et al. · 2021 · Journal of the International Neuropsychological Society
  93. Sars-CoV-2 and black population: ACE2 as shield or blade?
    Mattia Vinciguerra, Ernesto Greco · 2020 · Infection Genetics and Evolution
  94. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2
    Kinan Drak Alsibai · 2020 · Medical Hypotheses
  95. Macrophage responses associated with COVID-19: A pharmacological perspective
    George W. Booz, Raffaele Altara, Ali Hussein Eid, Zena Wehbe, Souha A. Fares, Hassan Zaraket, Nada J. Habeichi, Fouad Anthony Zouein · 2020 · European Journal of Pharmacology
  96. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries
    Li Ni, Linwen Zhu, Lebo Sun, Guofeng Shao · 2021 · Stem Cell Research
  97. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
    Jorge Pérez, César Augusto Prócel Ramírez, Cristina Cañadas, Diana Aguirre, Ronny Pibaque, Ricardo Bedón-Galarza, Fernando Sempértegui, Hemmo A. Drexhage, Lucy Baldeón · 2021 · Vaccines
  98. SARS-CoV-2 diagnosis using medical imaging techniques and artificial intelligence: A review
    Narjes Benameur, Ramzi Mahmoudi, Soraya Zaid, Younes Arous, Badii Hmida, Mohamed Hédi Bedoui · 2021 · Clinical Imaging
  99. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19
    Radu-Ştefan Miftode, Antoniu Octavian Petriş, Viviana Onofrei Aursulesei, Corina Maria Cianga, Irina Iuliana Costache, Ovidiu Mitu, Ionela-Larisa Miftode, Ionela-Lăcrămioara Șerban · 2021 · Diagnostics
  100. The Unique Impact of COVID-19 on Human Gut Microbiome Research
    Ella Burchill, Eva Lymberopoulos, Elisa Menozzi, Sanjay Budhdeo, James Roger Mcilroy, Jane Macnaughtan, Nikhil Sharma · 2021 · Frontiers in Medicine